As stay-at-home orders are taking their toll on the economy and businesses are in need of cash, the private equity industry could be well positioned to pick up better priced assets in the backwaters of the crisis. David Mussafer, chairman and managing partner of Advent International, told the Financial Times
The number of carve-out acquisitions is expected to rise as businesses look to restructure following the Covid-19 crisis. New research has revealed that around a fifth of carve-outs result in millions of dollars wasted because of inefficiencies, however. A survey, commissioned by TMF Group, found that 34 per cent of
Eurazeo is creating a EUR10 million solidarity fund to buy and donate products from its investee companies to support communities affected by Covid-19, with the support of its shareholders. The fund will be financed from Eurazeo’s cash holdings and by donations from the supervisory board, the executive board and the
Inflexion Private Equity Partners is making donations totalling GBP 2.5 million to help alleviate the impact of the coronavirus outbreak via The Inflexion Foundation. Inflexion said that the current pandemic is both “universal and severe” and that the firm recognises the need to support the most vulnerable at this time.
The British Private Equity & Venture Capital Association (BVCA) has recommended the UK Government introduces a GBP500 million funding facility for VC-backed, early stage companies operating in the digital, biotech and life sciences sectors during the Covid-19 crisis. Early stage businesses have been a key driver in establishing the UK
“The greater the obstacle, the more glory in overcoming it.” – Molière These are extraordinary times; a defining moment in our collective history. Covid-19 has forced over one billion of the world’s population into lockdown, and while many businesses are adjusting to remote working, the repercussions for non-human contact
The unfolding Covid-19 induced financial crisis is creating problems for private equity funds currently out on the road fundraising. Moreover, first time fundraisers out there in the market will struggle to reach fund closes this year, and even fewer debut managers are expected to launch new vehicles in the current climate.
CEPRES, a provider of portfolio forecasting for Private Markets, is advising clients to use 10 per cent VaR (Value at Risk) forecasts for 2020 and 2021 due to the COVID-19 outbreak. CEPRES projects outcomes for more than 100 Institutional investor portfolios around the world including pensions, insurers and endowments based on
As an asset class with a buy-to-sell cycle that typically lasts around five to seven years, you would be forgiven for thinking that private equity could weather the storm of Covid-19 more smoothly than other, more inherently volatile asset classes, can. That’s partly true.
Kenyan health tech startup Afya Rekod is about to launch an AI and blockchain consumer-driven, health data platform in support of global efforts to curb the coronavirus pandemic. The platform will provide a portal for people across the world to store their health data in real time, with a special
12 September, 2024 – 6:00 pm
05 June, 2024 – 8:30 am
24 October, 2024 – 8:30 am
14 November, 2024 – 8:00 am
